Although the odds of death were not associated with the baseline vitamin D level, they “decreased significantly by 46% for a 2-fold higher level of 25-hydroxyvitamin D,” Dr. Viard reported.
…”Similarly, CRP [C-reactive protein] was higher in cases than in controls at the latest sample for AIDS-events and death, and it was also higher at baseline for people who were going to die. CD14 levels were higher in cases and in controls for AIDS events and death.”
…CD4 counts increased by 7.00% per year for people deficient in vitamin D and by 11.14% per year for people nondeficient in vitamin D (both P < .01), but not at all for patients who were severely deficient.
…Asked for perspective on these findings, session cochair Andrea Antinori, MD, from the National Institute for Infectious Disease in Rome, Italy, who was not involved with the study, told Medscape Medical News that he found the results interesting because “probably we don’t have much information about the role of vitamin D, and more interestingly, not only its role in bone mineral density and fracture in the long term but even in immune activation inflammatory pathways” that can increase other risks, for example, for cardiovascular disease.
In other words, remaining haziness on vitamin D’s immune-enhancing functions makes it hard to discern if AIDS is exclusively or at all caused by HIV.
While holed up in London’s Ecuador embassy, it seems Wikileaks founder Julian Assange is using a lamp to create some vitamin D.
One can only hope that he was attracted to the idea from a certain London-authored book!…
[Source: Reuters: http://www.reuters.com/article/2012/08/20/us-wikileaks-assange-embassy-idUSBRE87J0LP20120820]
Taking vitamin D does not increase the risk for kidney stones, the study found. People’s age, gender and weight, however, may play a role in developing the condition.
…The new study used data on more than 2,000 adults of all ages. After following the participants for 19 months, researchers found that only 13 people reported being diagnosed with a kidney stone during that time
…Men also are at greater risk for kidney stones than women, the study found. But vitamin D users are not, it suggested.
As a comment, I’ve been taking high dose D for about seven years now and have never had an episode of kidney stones.
One in four black men will develop prostate cancer in their lifetime – double the figure for all men.
…The chance of developing prostate cancer in a lifetime is one in eight for all men, rising to one in four for black men.
Genetics or environment, or genetics and environment? Read my book.
[Source: Daily Mail. Prostate Cancer UK]
Prof Ian Reid, lead study author, from the University of Auckland, said the findings [of a new meta-analysis of all vitamin D studies to date] showed that healthy adults did not need to take vitamin D supplements.
“Our data suggest that the targeting of low-dose vitamin D supplements only to individuals who are likely to be deficient could free up substantial resources that could be better used elsewhere in healthcare.”
This study of studies relies on data from “inception to July 8, 2012… of vitamin D (D3 or D2, but not vitamin D metabolites) on bone mineral density.” The major problem with that is historical low-dose trials, mostly with D2. It also talks nothing of other diseases and the various barriers most people having in making vitamin D.
This media blow to vitamin D activism is an indirect victory to Big Pharma.
[Source: BBC News, contains link to meta-analysis]
If you’re a redhead and have the misfortune of being made fun of for that, it might be worth pointing out that you’re a wonderful product of evolution!
Fair skin and red hair first appeared around the time people settled in Europe 50,000 years ago and still remains a dominant gene in southern Europeans today, even if they can catch a tan.
Known as V6OL allele, the gene made skin lighter as humans were getting less vitamin D from no longer being in the harsh African sun.
[Source: Daily Mail]
“There is very little benefit to statin drugs for patients in the early stages of kidney disease, and no benefit or possible toxicity for patients in later stages,” said Ali Olyaei, a professor of pharmacotherapy in the College of Pharmacy at Oregon State University, and lead author on the new report.
…The impetus to use statin drugs – some of the most widely prescribed medications in the world to lower cholesterol – is obvious in end-stage kidney disease, because those patients have a mortality rate from coronary heart disease 15 times that of the general population. Unfortunately, evidence shows the drugs do not help prevent mortality in that situation. There is also no proven efficacy of the value of statins in patients using dialysis, researchers said.
[Source: News Medical]